Upgrade to SI Premium - Free Trial

West Pharmaceutical (WST) PT Raised to $310 at Barclays

April 24, 2026 4:08 PM
Barclays analyst Luke Sergott raised the price target on West Pharmaceutical (NYSE: WST) to $310.00 (from $275.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change